Pruritus Therapeutics Market, Revenue Growth, Key Factors, Major Companies, Forecast To 2028

ruchawaikar

Saiyan
Oct 4, 2023
236
0
16
The Pruritus Therapeutics Market is projected to surpass USD 19.98 Billion by 2028, up from USD 12.40 Billion in 2020, demonstrating a Compound Annual Growth Rate (CAGR) of about 6.2% throughout the forecast period. The increasing prevalence of skin diseases is expected to be a key factor propelling the Pruritus Therapeutics Market.

Pruritus is often linked to primary skin disorders such as Atopic Dermatitis, xerosis, drug eruption, psoriasis, urticaria, arthropod assault, dermatitis herpetiformis, and Mastocytosis. These skin disorders lead to an unpleasant sensation that triggers the urge to scratch or itch. Pruritus has long been linked to various systemic diseases, and its severity can range from mild itchiness to a persistent, debilitating condition. Generalized pruritus, categorized based on the underlying causative disease, includes cholestatic pruritus, renal pruritus, hematologic pruritus, idiopathic generalized pruritus, endocrine pruritus, and pruritus related to malignancy. Notably, chronic pruritus is frequently observed in pregnant women, affecting approximately 18% of all pregnant women.

Get a sample of the report @ https://www.reportsanddata.com/download-free-sample/1176

Competitive Landscape:


Key players contributing towards the global pruritus therapeutics market are Allergen, Bristol-Myers Squibb, Astellas Pharma, GlaxoSmithKline, Eli Lilly, Novartis, Merck, Sanofi, and Pfizer. These players are focusing on expanding their product portfolios by binging novel therapies for skin diseases. On July 22, 2020, a commercial-stage pharmaceutical company MC2 Therapeutics, which is developing a new standard of topical therapies for chronic inflammatory conditions, announced approval Wynzora® Cream (betamethasone dipropionate and calcipotriene, w/w 0.064%/0.005%) by the FDA. The cream is a topical treatment for plaque psoriasis in adults 18 years or above. The pharmaceutical company is focused upon the development of its pipeline of novel topical therapies for chronic inflammatory indications, including uremic pruritus, atopic dermatitis, dry eye, and lichen sclerosus.

To know more about the report @ https://www.reportsanddata.com/report-detail/pruritus-therapeutics-market

Driving Factors Of Pruritus Therapeutics Market


  1. Growing Prevalence of Skin Diseases: The increasing incidence of skin disorders such as Atopic Dermatitis, xerosis, drug eruption, psoriasis, urticaria, arthropod assault, dermatitis herpetiformis, and Mastocytosis is a major driving force for the Pruritus Therapeutics Market.
  2. Rising Cases of Chronic Pruritus: The prevalence of chronic pruritus, particularly in specific populations like pregnant women (affecting around 18% of all pregnant women), is contributing to the expansion of the Pruritus Therapeutics Market.
  3. Association with Systemic Diseases: Pruritus has longstanding associations with systemic diseases, and the recognition of its link to conditions such as cholestatic pruritus, renal pruritus, hematologic pruritus, idiopathic generalized pruritus, endocrine pruritus, and pruritus related to malignancy is driving the demand for therapeutic interventions.
  4. Increasing Awareness and Diagnosis: Growing awareness about pruritus and improved diagnostic capabilities are leading to an increased number of individuals seeking treatment, thereby boosting the demand for pruritus therapeutics.
Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/1176

About Us:


Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market.

Contact Us:

John W


(Head of Business Development)

Reports and Data | Web: www.reportsanddata.com

Direct Line: +1-212-710-1370a

E-mail: [email protected]

Blogs | Press Release | Industry News | Our competencies

Browse More Upcoming Reports @ https://www.reportsanddata.com/upcoming-reports

Browse More Latest Reports @ https://www.reportsanddata.com/report